Pancreatic Cancer Trial, Recruiting NCT05975593 Sponsor: Washington University School of Medicine Condition: Pancreatic Cancer
Back to Pancreatic Cancer

Pancreatic Cancer Trial, Recruiting

NCT05975593
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are planning to receive radiotherapy (radiation treatment) for either cervical cancer or pancreatic cancer
  • People who are reasonably able to carry out daily activities with little to no limitation from their illness (this is measured on a standard scale used by doctors, confirm with trial site)
  • People who are at least 18 years old
  • People who are able to understand and are willing to sign an official consent form approved by an ethics review board

Who may not be able to join:

  • People for whom the treating doctor determines that collecting blood or tissue samples (called biospecimens) would not be safe, for any medical, physical, or other reason

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cliff Robinson, M.D., Washington University School of Medicine

Phone: 314-362-8567

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
11 January 2024
Est. completion
31 December 2032

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Changes in tumor microenvironment

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov